Daniel Burton’s transition deal at Health Catalyst (HCAT) details advisory role

robot
Abstract generation in progress

Health Catalyst (HCAT) has outlined a transition agreement with former CEO Daniel Burton, who retired on February 12, 2026. He will serve as a strategic advisor until December 31, 2026, receiving a monthly base salary of $10,000. As part of the agreement, Burton will forfeit unvested restricted stock units and provide a general release of claims against the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin